Integrated Biosciences Inc., an early-stage startup that is combining synthetic biology and machine learning in the hunt for drugs that tackle cell senescence, has demonstrated its capabilities in a newly published study in Nature Aging on May 4, 2023, which employed artificial intelligence (AI) to identify three novel compounds that are highly selective for Bcl-2 and that exhibit favorable medicinal chemistry profiles.

In an age of overwhelming volumes of data that don’t fall together effortlessly into a lucid representation of reality, computational power is often the vital ingredient in leveraging existing data to push the frontiers of medicine. The Cleveland Clinic and IBM unveiled a quantum computing center that provides the sheer computational power needed to sort through the avalanche of data at a pace that will provide real insights into drug development and disease prediction, a development that portends truly revolutionary advances in disease prevention and treatment.